Share This Page
Drugs in ATC Class D02B
✉ Email this page to a colleague
Subclasses in ATC: D02B - PROTECTIVES AGAINST UV-RADIATION
Market dynamics and patent landscape for ATC Class D02B (Protectives against UV-radiation)
ATC D02B is the topical dermatology space for UV photoprotection, covering sunscreens and related actives used to reduce UV-induced skin damage. The market is shaped by regulatory UV labeling rules, consumer adoption of broad-spectrum claims, ingredient substitution driven by safety and environmental scrutiny, and continued formulation innovation to improve photostability, wearability, and cosmetic acceptance. Patent activity concentrates in: (i) combinations of organic UV filters and stabilizing systems, (ii) broad-spectrum claims targeting UVA/UVB and, increasingly, high-energy visible (HEV) and infrared reduction, (iii) photo-stabilization and photoreactivity control, and (iv) device-like delivery formats (films, sticks, powders, and controlled-release vehicles).
How big is the UV-protective topical market and what drives growth?
Market size depends on whether companies include only “sunscreen” or also extend into after-sun, anti-aging, and UV-related skin care. For patent strategy, the key growth drivers are consistent:
-
Broad-spectrum adoption and claim enforcement
- Consumers and regulators reward products that cover UVA and UVB with stable performance across the labeled period.
- Patent filings reflect this via UVA/UVB filter system optimization, boosting photostability and maintaining spectral coverage over time.
-
Formulation innovation as the primary moat
- Active ingredients are well-known, so patents increasingly protect compositions and processes: combinations, emulsifier systems, particle engineering, and stabilizer packages.
-
Safety and environmental pressures on specific UV filters
- Public and regulatory scrutiny influences which filters companies prefer and how quickly they reformulate.
- This pushes patent filings toward alternative filters, hybrid systems, and new stabilizers that mitigate photodegradation and potential irritancy.
-
Cosmetic performance as a differentiator
- “Wearability” parameters (whitening, stickiness, texture, residue) determine market share.
- Patents increasingly target vehicle engineering to improve spreadability and film formation.
What are the commercial segments within D02B?
Patent-relevant segmentation for market dynamics:
-
Filters and filter systems
- Organic UV filter combinations (UVA and UVB coverage)
- Inorganic UV blockers (e.g., titanium dioxide, zinc oxide) in engineered forms
- Hybrid systems combining organic and inorganic filters
-
Formulation formats
- Cream/lotion emulsions
- Gels and sprays
- Sticks
- Powders and film-forming compositions
- Encapsulated or structured delivery formats
-
Performance-enhancement systems
- Photo-stabilizers and stabilizing polymers
- Antioxidants and radical scavengers
- Film formers and rheology modifiers
- Humectants and barrier-compatible excipients aimed at improved tolerance
How does regulation shape patent strategy in UV protection?
Patent activity tracks regulatory requirements for UV protection claims, broad-spectrum labeling, and photostability expectations. Companies typically patent:
- Filter combinations designed to satisfy spectral coverage targets while meeting safety tolerability profiles
- Photo-stabilization approaches to preserve UVA/UVB efficacy under real-world irradiation conditions
- Compositional constraints that improve stability during shelf life and use
The patent landscape also reflects the practical enforcement reality: many competitors can copy a single known UV filter, but they cannot easily replicate a proprietary combination, processing method, particle engineering, or vehicle design without infringing composition/process claims.
Which patent themes dominate ATC D02B?
1) Broad-spectrum UVA/UVB filter combinations
Most patents do not claim a novel “UV concept.” They claim formulations that balance:
- UVA and UVB coverage
- Photostability (resistance to filter degradation)
- Skin feel and tolerance
Typical claim patterns include:
- “A composition comprising” two or more specific filters
- Ratios or concentration ranges
- Requirements for specific spectral behavior or stability outcomes
2) Photostabilization and reduction of photoreactivity
Photostability is a consistent driver. Patents cover:
- UV filter stabilizers
- Antioxidant packages that reduce oxidative degradation
- Polymer or film-former systems that limit filter breakdown
- Encapsulation or controlled dispersion to reduce direct photochemical interactions
3) Inorganic filter engineering
Inorganic filters are often patent-protected via:
- Particle size and coating chemistry
- Surface modifications to reduce irritation and improve cosmetic appearance
- Dispersion systems that minimize aggregation and enhance film uniformity
4) Novel delivery formats and structured vehicles
Form factors and structured vehicles frequently generate enforceable differentiation:
- Micro- or nano-structured delivery
- Film-forming compositions (including polymers and polymer blends)
- Water-resistant or sweat-resistant systems that preserve filter distribution
5) Expansion into HEV/infrared and skin damage mitigation beyond UV
A growing number of filings claim protection beyond classical UV:
- Reduction of visible light-induced oxidative stress
- Infrared-related skin warming or barrier impact mitigation
- Anti-inflammatory or antioxidant add-ons tied to photodamage outcomes
Even when HEV claims differ from classical sunscreen regulatory definitions, the R&D logic is the same: lock in performance with multi-active formulations and test-based thresholds.
Which companies and patent players are most active?
The ATC D02B space is concentrated among global consumer health and dermocosmetics groups and large multinational pharmaceutical-adjacent skincare players. Patent activity commonly clusters around:
- Multi-national consumer product companies
- Building global brands around photoprotection lines and seasonal demand cycles
- Specialty ingredient and formulation houses
- Providing novel filter systems, stabilizers, and delivery technologies
- Chemical and materials innovators
- Patenting particle engineering, coatings, and film-former technologies used by downstream formulators
While exact “top assignees” require database-level extraction, the structural pattern is robust: the highest-density portfolios sit with brands that already sell sunscreen at scale, because they can justify R&D and regulatory testing costs.
Where are patent barriers likely to be highest?
In D02B, the most defensible patent barriers are not typically “single-filter” inventions. They are:
- Filter system compositions with defined ratios
- Processing methods for particle dispersion and stabilization
- Film-forming vehicle designs
- Photo-stabilizer packages that preserve UVA/UVB coverage
- Structured delivery formats
For market entry, a competitor can often replicate basic SPF/UVA coverage, but it can struggle to match:
- Specific spectral coverage durability
- Photostability over repeated exposure
- Cosmetic performance tied to proprietary vehicle engineering
- Water resistance profiles tied to structured film formation
What does the competitive patent strategy look like across a product lifecycle?
Typical lifecycle pattern:
- Base filter/vehicle platform patents
- Early patents cover the core filter combination and vehicle architecture.
- Stability and performance continuation filings
- Improvements target photostability, oxidant control, wear time, and residue reduction.
- Regulatory and claim-aligned reformulation
- As safety and regulatory guidance shifts, companies file continuation patents on alternative actives or adjusted ratios.
- Form-factor and regional strategy
- Stick, spray, powder, and “sensitive skin” variants generate families tied to formulation constraints.
The result is a layered landscape where “freedom to operate” (FTO) must be assessed at family level and by formulation archetype, not just by active ingredient.
How does IP interact with regulatory UV labeling and testing?
Patent claims often track measurable endpoints used in commercialization:
- UVA/UVB balance and broad-spectrum characterization
- SPF determination (where applicable)
- Photostability tests
- Water resistance persistence
This alignment matters because marketing claims drive repeat testing, and testing outcomes generate the data points that support claim language. When companies draft claims around stability and spectral behavior, they reduce the ability of copycat formulations to design around without re-testing.
Key risks in the D02B patent landscape for R&D teams
- Design-around is expensive
- A “different filter” is rarely enough. Many patents are combination-based and vehicle-dependent.
- FTO is formulation-specific
- Copying a label ingredient list can still infringe if the protected combination, concentration range, or stabilization system overlaps.
- Continuation filings maintain coverage
- Even after base patents expire, improvement patents may remain in force.
- Global filing creates parallel obligations
- Sunscreen is heavily commercialized in multiple jurisdictions, increasing the likelihood of multi-country grants in the same families.
Market outlook implications for patent strategy
For new entrants and investors, the patent landscape implies:
- Best route to differentiation is performance and stability, not just actives
- Invest in photostability, delivery structure, and cosmetic wear metrics.
- Avoid “single-parameter” inventions
- Patents that only address SPF or only describe a single stabilizer without specifying system performance face higher invalidity/design-around risk.
- Focus on claim scope that matches consumer outcomes
- When R&D tests for real-world performance are translated into claim requirements, infringement becomes more likely in products that target the same outcomes.
Key Takeaways
- ATC D02B is dominated by formulation and combination patents for UVA/UVB broad-spectrum photoprotection, with strong focus on photostability, wearability, and delivery structure.
- Market growth is driven by broad-spectrum adoption, regulatory UV labeling expectations, consumer cosmetic preferences, and safety-driven ingredient substitution, pushing companies into continuous formulation innovation.
- Patent barriers are highest for composition systems with defined ratios, photo-stabilization packages, and vehicle/particle engineering that preserve spectral coverage and cosmetic performance over time.
- Competitive portfolios tend to evolve through platform filing plus continuation families, making FTO a product archetype and family-level exercise, not just an ingredient checklist.
- The most investable technical targets are systems that deliver measurable real-world outcomes: durable UVA/UVB coverage, resistance to photodegradation, and skin-tolerable, residue-minimized film formation.
FAQs
1) What type of patents most often protect UV filter products in D02B?
Composition and process patents for UV filter combinations, photostabilizing systems, and formulation/vehicle architectures.
2) Why do companies file around photostability rather than only SPF?
Photostability and broad-spectrum persistence translate into regulatory-relevant performance and difficult-to-copy formulation architecture, giving stronger enforceability than a single SPF number.
3) Are inorganic filters and organic filters protected differently in patents?
Yes. Inorganic filters are often protected through particle size, coating, and dispersion. Organic filters are often protected through combination ratios and stabilizer packages.
4) What drives continuation filings in UV photoprotection?
Changes in ingredient policy, improved wearability, better stability outcomes, and new formats (sprays, sticks, powders) generate follow-on claim sets.
5) What is the highest FTO risk area for formulators?
Using a common ingredient list without controlling for protected combinations, concentration windows, stabilization systems, and structured vehicles.
References
[1] European Commission. “Cosmetics Regulation (EC) No 1223/2009.” EUR-Lex. https://eur-lex.europa.eu/ (accessed via legal framework on cosmetics and safety requirements).
[2] US FDA. “Sunscreen Drug Products for Over-the-Counter Human Use: Proposed Rule.” Federal Register / FDA materials on UV filters and sunscreen regulatory framework. https://www.fda.gov/ (accessed via FDA sunscreen regulatory content).
[3] WHO. “Sun protection and UV radiation.” World Health Organization UV guidance. https://www.who.int/ (accessed via UV and sun protection materials).
More… ↓
